Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. - sprookjes - yvandenbroek - TriplyDB

Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis.

Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis.

http://www.wikidata.org/entity/Q36164951

about

Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions.Memory deficits, gait ataxia and neuronal loss in the hippocampus and cerebellum in mice that are heterozygous for Pur-alpha.Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.Effects of information processing speed on learning, memory, and executive functioning in people living with HIV/AIDS.Drugs of Abuse in HIV infection and neurotoxicity.Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter.HIV eradication symposium: will the brain be left behind?Chronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae infection model.Curcumin improves synaptic plasticity impairment induced by HIV-1gp120 V3 loop.Facial emotion recognition impairments are associated with brain volume abnormalities in individuals with HIV Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection.Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort.Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity Role of Histidine 547 of Human Dopamine Transporter in Molecular Interaction with HIV-1 Tat and Dopamine Uptake Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders.Functional brain abnormalities during finger-tapping in HIV-infected older adults: a magnetoencephalography study HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations.Neurocognitive and neuroinflammatory correlates of PDYN and OPRK1 mRNA expression in the anterior cingulate in postmortem brain of HIV-infected subjects.Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport Synaptodendritic injury with HIV-Tat protein: What is the therapeutic target?Update on HIV dementia and HIV-associated neurocognitive disorders.Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered.Computational modeling of human dopamine transporter structures, mechanism and its interaction with HIV-1 transactivator of transcription.N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders.D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity.The role of human dopamine transporter in NeuroAIDS.Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory.When do models of NeuroAIDS faithfully imitate "the real thing"?Heme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infection.The role of catecholamines in HIV neuropathogenesis.HIV-1 proteins dysregulate motivational processes and dopamine circuitry.

P2860

Q26865707-CA745354-171B-4D08-8B1D-BC4C08127A7A Q28709047-4C9EE1AA-85FF-43A3-A6CE-833D427956FF Q33808035-A1E63084-A7F6-4F85-B719-D33F41D30643 Q34343025-B44D18E3-951C-4E0C-A684-34F826DBF7DC Q34540818-C8E0878E-1871-4FF3-998C-F2762B973F7C Q35000860-8C271C88-3B82-4B27-AD85-295032278FED Q35115524-D408015B-7095-4075-9289-D85DC5A4B3B0 Q35212027-9C987B25-072D-42BA-902C-D83678321882 Q35450098-58F47D30-6A47-44C4-865A-E2C91A00C47B Q35607587-708DF721-CD68-49F2-908C-31C087FD6E65 Q35814647-68151EC5-A392-49B7-AF37-EC4679E5B8D3 Q35837978-E45F6641-54BC-4F6C-8A25-954245950FB7 Q35867609-AE3CBE3F-CF3A-459F-AFE4-670102DCDA14 Q36845234-39CF3E54-81C5-47B2-8B8A-6E8FE216BD8B Q36875652-913A557D-28F0-4797-BC68-9EFED6266778 Q36953079-E612B9C3-5302-47CE-996B-19C6C432D607 Q36960223-5B21905E-7F1D-4701-B7FE-F8D365083147 Q36989549-35B6151B-F09F-431D-B5B8-7C8830C7D701 Q37257522-561E98DD-49BB-47C6-A7A8-E66F0419294F Q37376944-4112215C-B862-4978-B442-F50800913053 Q37496856-AB5FDC9C-AFB6-4ED9-925F-A222A9B3DCF8 Q37501478-9FDA32E7-A3F6-43E0-8741-75FEC2D85C31 Q37597459-0F4701F3-7AF8-4C3F-BA8F-A5FEE0880881 Q38220991-75F0E55F-3788-4928-9FA1-76429B90349D Q38414358-4516B0C2-E0A2-4D49-A89F-76B77E3BD9F7 Q38811823-03CB7E2D-2D5F-4EC7-B06D-A132D5F091FD Q40113255-BA03071A-F926-45CA-AD1C-59F8DD1CDACA Q40182651-36F94CE3-8FF6-47BF-A4B5-E0D45AEC2ADC Q41922188-8B525B50-E583-4501-987B-E69EC62F3098 Q42429157-5D8B0400-6E54-4869-AF8C-EA9F462C4D8D Q47563724-FF639C19-36C4-41E1-93A6-4E7894ACE8C9 Q51743775-50A9A464-EAEB-47BD-B098-FF99E9EA77B6 Q53828206-D3D54D8D-015B-43D9-B165-FD5A3C1EFF0B Q55309956-BABA55A7-354F-495F-B74E-4BF2160CC3B1

P2860

Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis.

http://www.wikidata.org/entity/Q36164951

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Prefrontal dopaminergic and en ...... ve disorders and encephalitis.

@ast

Prefrontal dopaminergic and en ...... ve disorders and encephalitis.

@en

type

label

Prefrontal dopaminergic and en ...... ve disorders and encephalitis.

@ast

Prefrontal dopaminergic and en ...... ve disorders and encephalitis.

@en

prefLabel

Prefrontal dopaminergic and en ...... ve disorders and encephalitis.

@ast

Prefrontal dopaminergic and en ...... ve disorders and encephalitis.

@en

P1433

Q36164951-BF39F075-A761-4330-BA1E-FDA860D4E3A9

P1476

Q36164951-6FAE2109-88C3-4C4E-A1A2-2914EC5DDB3F

P2093

Q36164951-483164E4-F165-46F5-AB81-85F7D2522237

Q36164951-60627696-2F7D-41A0-8947-9BC63196788A

Q36164951-6803926F-A408-46A4-913C-02C2C1D58FEE

Q36164951-9E6CE40B-3427-4BDD-941E-103295A998A7

Q36164951-B2EE24F3-C82E-42E7-AE0D-95C7E02F54F5

Q36164951-B4977B65-8E61-4455-8588-DBCFDD7A15BC

Q36164951-E1DE3787-47FE-4497-9996-C9531D7B33A9

P2860

Q36164951-004C2A13-9271-4940-B5E2-C5F9B6DFDCBC

Q36164951-01C71DB9-DC9F-4133-B7BA-C9106842338E

Q36164951-02F2ADAD-3DAA-48E1-9F0B-609A863E4BA0

Q36164951-05F3EE58-B24A-40E3-AA0E-97148843562D

Q36164951-06F46090-8C7D-4903-8F0E-D0945E62257F

Q36164951-07818EBD-5490-405B-B98C-A45DF4C9F8B6

Q36164951-0ABA391A-36EB-47BA-BD63-65802251D496

Q36164951-0FF4868F-7B1A-4A16-B0D3-5E70659BBFB7

Q36164951-100E5911-3B4B-4E51-997D-29B67A640D3C

Q36164951-103A841F-3737-4C70-A842-F142DA88C31D

P2888

Q36164951-EB826E10-B68D-4866-93AA-9F9A8E6CA231

P304

Q36164951-42E37C31-222D-4AFF-BB5C-FD11BE8C80E8

P31

Q36164951-B6071B56-8DE3-404B-BF51-E41340243324

P356

Q36164951-F5443D55-9DAD-459A-ACF5-45858D42BE37

P433

Q36164951-53929779-326B-458D-949C-72A51660470C

P478

Q36164951-8D41C7ED-FC21-4AC3-A873-8F4139A6A673

P577

Q36164951-EF6FA16C-7458-4793-8D0E-748156D7588F

P5875

Q36164951-6BB902E1-BBC2-45FC-A7D2-C752DE5EE4DB

P698

Q36164951-091F4B15-848E-415B-9117-2AA0DBDD2B50

P921

Q36164951-02660419-B0C1-42C0-9D59-710080054922

P932

Q36164951-CD4D5DEF-F098-4B84-86BC-23F7254D4588

P356

S11481-012-9345-4

P1433

Journal of Neuroimmune Pharmacology

P1476

Prefrontal dopaminergic and en ...... ve disorders and encephalitis.

@en

P2093

Benjamin B Gelman

http://www.w3.org/2001/XMLSchema#string

Daniel H Freeman

http://www.w3.org/2001/XMLSchema#string

Joshua G Lisinicchia

http://www.w3.org/2001/XMLSchema#string

Kenneth M Johnson

http://www.w3.org/2001/XMLSchema#string

Kristofer Jennings

http://www.w3.org/2001/XMLSchema#string

Tianshen Chen

http://www.w3.org/2001/XMLSchema#string

Vicki M Soukup

http://www.w3.org/2001/XMLSchema#string

P2860

Cognitive neuropsychology of HIV-associated neurocognitive disorders

Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

Synaptic plasticity: multiple forms, functions, and mechanisms

Substance P and neurokinin-1 receptor modulation of HIV

Molecular characterization of immune derived proenkephalin mRNA and the involvement of the adrenergic system in its expression in rat lymphoid cells

Cognitive functioning in patients with bipolar disorder: association with depressive symptoms and alcohol use

under dependency

Mechanisms Underlying Differential D1 versus D2 Dopamine Receptor Regulation of Inhibition in Prefrontal Cortex

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

P2888

s11481-012-9345-4

P304

686-700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11481-012-9345-4

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221889494

http://www.w3.org/2001/XMLSchema#string

P698

22391864

http://www.w3.org/2001/XMLSchema#string

P921

P932

3419353

http://www.w3.org/2001/XMLSchema#string